Pharmaceuticals

More info

Parent markets

Sibling markets

Related markets

500+ companies in Pharmaceuticals
Show all

Merck

Health Care +2

AbbVie

Biotechnology +1

Allergan plc

Biotechnology +1

Sanofi

Pharmaceuticals

GSK

Health and Wellness +2

TransEnterix

Health Care +2

Roche

Biotechnology +3

AstraZeneca

Biotechnology +1

Intrexon

Biotechnology +2

Bristol-Myers Squibb

Health and Wellness +2

Novo Nordisk

Biotechnology +1

Takeda

Pharmaceuticals +1

Atomwise

Artificial Intelligence +2

Galena Biopharma

Biotechnology +1

Cellectar

Biotechnology +1

All companies in Pharmaceuticals

Built with ❤︎ by Datalicious ©2018
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

News

Funding rounds

Acquisitions

Companies

Investors

Companies

597

Established hub

Add companies

Deals 2018 Q1

23 investments

2 acquisitions

Index Pro Account

Upgrade your account to download a CSV export of companies on any list

Upgrade account

Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs

Health Strategy

P&G to buy German Merck's consumer health biz, makes open offer for India unit

Strategy Health

Sanofi in talks to sell generics arm to Advent for $2.4 billion: Reuters

Funding Strategy Health

Rawadi named CEO of LNC Therapeutics

Health Science

Your hospital won't be buying drugs from Amazon after all.

Health Retail

Merck Tightens Its Grip on the Lung-Cancer Market

Health

Despite Pain Drug’s Mid-Stage Miss, Adynxx Plans a Larger Phase 3 Test

Health

As Novartis Buys In to Gene Therapy, GSK Bows Out with Orchard Deal

Health Science Stock markets

Constellation Pharmaceuticals attracts $100 mln

Messaging

Bio Roundup: Ex-Kiters Say Allo, NASH Cash & Data, Alkermes No & More

Health Science

Irish medtech startup Diaceutics raises €4.3 million in mezzanine funding

Funding

HCL Tech to acquire Merck unit C3i Solutions for $60 mn

Strategy

Conatus Pharma’s Liver Disease Drug Flunks First Phase 2 Test

Health

VC-backed Roche Holdings buys Inception 5 program

Funding Science

AbbVie Has a Growing Credibility Problem

Health Earnings

GSK buys out Novartis in $13 billion consumer healthcare shake-up

Mereo BioPharma files for IPO

Stock markets

Racing Allergan, Biohaven Touts Migraine Drug Data, But Shares Sink

Health

Dracen Pharmaceuticals Bags $40M in Series A

$36,000,000 Venture capital (Series A)

, ,

New York firm leads Series A for Baltimore-based Dracen Pharmaceuticals

Health Funding Science

Index

By TNW

Pharmaceuticals

Merck

AbbVie

Allergan plc

Sanofi

GSK

TransEnterix

Roche

AstraZeneca

Intrexon

Bristol-Myers Squibb

Novo Nordisk

Takeda

Atomwise

Galena Biopharma

Cellectar

News

Funding rounds

Acquisitions

Companies

Investors